RecallRadar
ModerateReported November 4, 2026 (2 weeks ago)

PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chlori…

Recalled by Eagle Pharma Outsourcing LLC

Drug recall

Eagle Pharma Outsourcing LLC

Class II — moderate

Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Eagle Pharma Outsourcing LLC has recalled PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chlori…, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on November 4, 2026 and was initiated on October 8, 2026. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.

What was recalled?

This recall covers PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chlori…, with approximately 50 250 mL-containers affected. The company behind the recall is Eagle Pharma Outsourcing LLC, based in Hoover, AL. The FDA describes the product as: “PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985210025. NDC 69852-100-25”

Why was PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chlori… recalled?

According to the FDA, the stated reason for the recall is: “Lack of Assurance of Sterility.” In plain terms, this recall relates to a sterility or contamination concern.

Sterile medicines, such as injectables and eye drops, must be completely free of microorganisms and stray particles. This recall means that sterility could not be assured or that contamination was found or suspected. Using a non-sterile product of this kind can cause infections, which is why these recalls are treated seriously.

What should you do?

If you think you may have bought PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chlori…, compare it against the product description and identifying codes (Lot: PHENYL100-1004, Expiry: 12/31/2026.) before using it. This recall is currently listed as ongoing.

The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Eagle Pharma Outsourcing LLC or your local health authority.

About this recall

This recall was distributed in AL. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.

Who this recall affects

This recall matters to anyone who bought PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chlori…. Even if you feel fine, it's worth checking what you have on hand rather than assuming you were missed.

Distribution listed in the notice: Nationwide within the U.S.

What sterility or contamination concern actually means

Sterile medicines, such as injectables and eye drops, must be completely free of microorganisms and stray particles. This recall means that sterility could not be assured or that contamination was found or suspected. Using a non-sterile product of this kind can cause infections, which is why these recalls are treated seriously.

In this case, the concern applies specifically to PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chlori… from Eagle Pharma Outsourcing LLC — not to the wider category of products. Similar items from other brands aren't part of this recall.

How to check whether you have it

On medicine bottles, the lot number and expiration date are printed on the pharmacy label or stamped directly on the manufacturer's bottle — often near the bottom edge or on the back. If a pharmacy label covers it, your pharmacist can look up the lot they dispensed.

Compare what you find against the identifying details in this recall: Lot: PHENYL100-1004, Expiry: 12/31/2026.

What to do if you already bought it

Do not stop taking a prescribed medicine on your own because of a recall — for many conditions, an interrupted dose carries its own risk.

Instead, check the lot number against the details above and contact your pharmacist, who can confirm what they dispensed and arrange a replacement.

If you've had an unexpected reaction, contact your healthcare provider. Problems can also be reported to the FDA's MedWatch program.

Full recall details

Status
Ongoing
Date reported
November 4, 2026
Recall started
October 8, 2026
Distributed in
AL
What was recalled
PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985210025. NDC 69852-100-25
Why it was recalled (as stated by the FDA)
Lack of Assurance of Sterility
How to identify the affected product
Lot: PHENYL100-1004, Expiry: 12/31/2026.
Amount recalled
50 250 mL-containers

What you can do

Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.

Quick answers

Why was PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chlori… recalled?+

According to the FDA: Lack of Assurance of Sterility

How serious is this recall?+

Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.

What should I do if I have PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chlori…?+

Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.

Share this recall:PostShareEmail
View the official FDA record →

Opens the U.S. Food and Drug Administration (FDA) data for this recall.

Recall number: D-0105-2027. Information last synced from the FDA on November 22, 2026.

Related recalls